A practical reference on AOD-9604: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-05-04. Anything still debated is marked as such rather than presented as settled.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.
| Property | Value | Notes |
|---|---|---|
| Common synonym | hGH fragment 176-191 | Refers to the C-terminal segment |
| Appearance | White to off-white powder | Typically supplied lyophilized |
| Solubility | Soluble in water and aqueous buffers | Confirm with technical data |
| Typical storage temperature | -20 °C for dry powder | Protect from moisture and light |
| Common analytical method | RP-HPLC with UV detection | Often paired with mass spectrometry |
Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.
The peptide is frequently described as a growth hormone fragment, although it is chemically distinct from full-length hGH. AOD-9604 contains 16 amino acids and includes two cysteine residues that can form an intramolecular disulfide bond. In solution, this structural feature can influence folding, aggregation, and stability. Published descriptions sometimes call it hGH 176-191 or AOD9604, with spacing and capitalization varying. Such naming differences can complicate literature searches, database entries, and product verification.
Identity and purity are commonly checked with reversed-phase high-performance liquid chromatography and mass spectrometry. RP-HPLC separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry confirms molecular mass and helps detect sequence variants or truncations. Some laboratories use amino acid analysis or peptide mapping for additional characterization. No single method proves biological activity; these techniques establish chemical identity and purity only. They also require suitable reference standards for confident comparison.
Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.
AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
Regulatory treatment of AOD-9604 is shaped by its classification as a peptide hormone. The World Anti-Doping Agency lists it as a prohibited substance, and many national anti-doping organizations adopt that list. It does not hold approval as a prescription medicine in the United States, the European Union, or other major markets. Products sold online are frequently labeled for research use only and may not undergo independent quality testing. Import and possession rules differ by country, so legal status depends on local law.
Proposed mechanisms for AOD-9604 focus on fat cells. Laboratory studies suggest the peptide can increase lipolysis, the breakdown of stored fat, and reduce lipogenesis, the formation of new fat. Unlike full human growth hormone, it does not appear to stimulate substantial IGF-1 production in the studies reported so far. Some evidence points to beta-adrenergic signaling, but the precise receptor targets and downstream pathways remain unresolved. The fragment is not thought to act through the classical growth hormone receptor.
Berkelium(IV) fluoride (BkF4) is a yellow-green ionic solid and is isotypic with uranium tetrafluoride or zirconium tetrafluoride. Berkelium(III) fluoride (BkF3) is also a yellow-green solid, but it has two crystalline structures. The most stable phase at low temperatures is isotypic with yttrium(III) fluoride, while upon heating to between 350 and 600 °C, it transforms to the structure found in lanthanum trifluoride. Visible amounts of berkelium(III) chloride (BkCl3) were first isolated and characterized in 1962, and weighed only 3 billionths of a gram. It can be prepared by introducing hydrogen chloride vapors into an evacuated quartz tube containing berkelium oxide at a temperature about 500 °C. This green solid has a melting point of 600 °C, and is isotypic with uranium(III) chloride. Upon heating to nearly melting point, BkCl3 converts into an orthorhombic phase. Two forms of berkelium(III) bromide are known: one with berkelium having coordination 6, and one with coordination 8. The latter is less stable and transforms to the former phase upon heating to about 350 °C. An important property of radioactive solids has been studied on these two crystal forms: the structure of fresh and aged 249BkBr3 samples was probed by X-ray diffraction over a period longer than 3 years, so that various fractions of berkelium-249 had beta decayed to californium-249. No change in structure was observed upon the 249BkBr3—249CfBr3 transformation. However, other differences were noted for 249BkBr3 and 249CfBr3.
== History == Dalbavancin has undergone a phase-III clinical trial for adults with complicated skin infections, but in December 2007, the US Food and Drug Administration (FDA) said more data were needed before approval. Pfizer withdrew its marketing applications to conduct another phase-III clinical trial in September 2008. Durata Therapeutics acquired the rights to dalbavancin in December 2009, and has initiated two new phase-III clinical trials for treatment of ABSSSIs. Preliminary results in 2012 were promising. About 1,289 adults with ABSSSI were given dalbavancin or vancomycin randomly, and dalbavancin was found to exhibit efficacy comparable to vancomycin. In May 2014, dalbavancin was approved for medical use in the United States for ABSSSIs, including MRSA and Streptococcus pyogenes infections.
In the spring of 1948, Liu Wenhui's son Yuanyan, who was studying at West China University and had secretly come into contact with the Communist Youth League, came to Liu to act as an intermediary for negotiations with the Communist Party. However, Liu Wenhui told his son that he had already been in contact with the communists. This contact had happened in 1942, when Liu met with Zhou Enlai in Chongqing to discuss forming an anti-Chiang Kai-shek pact. Liu and Zhou reportedly agreed to jointly resist Chiang and to share intelligence; in a concession to the Xikang warlord, the communists also promised not to organize within Liu's 24th Army. This pact was exemplified by the existence of a covert communist radio station in Ya'an, established in June 1942 under the leadership of Wang Shaochun. This radio station provided Liu with pro-communist battle reports and propaganda, and operated continuously until 1949, helping coordinate the Chengdu Uprising. In 1947, after the Nationalists captured Yan'an and put the communist forces on the backfoot, Liu temporarily stopped providing funding to the radio station; however, he resumed support soon after. Zhou Enlai described Liu as a "political thermometer", who was "sometimes hot, sometimes cold" in his dealings with the Communist Party.
=== Structure === The structure of a nanogel is dependent upon the synthesis mechanism and its application. Simple or traditional nanogels are nanoparticle-sized crosslinked polymer networks that swell in water. Hollow nanogels consisting only of an outer shell can increase the amount of cargo loaded into the platform. In other nanogel structures, the inner core and outer shell can be made of two different materials, such as a hydrophobic inner core to surround drugs or other small molecules and a hydrophilic outer shell that interacts with the external environment. The addition of a second linear monomer crosslinked to a nanogel is deemed a "hairy nanogel". Different nanogel synthesis methods can be completed in sequential order to create multilayered nanogels, such as starting with ionotropic gelation and then combining anionic and cationic polymers in an aqueous solution. Functionalized nanogels, in which targeting ligands or stimuli-sensitive functional groups are conjugated to the outer shell of a nanogel, are also important for certain nanogel applications.
== Early life == Rosanna Jeanne Reardon was born on June 8, 1985, in Seattle, Washington, where she was raised alongside her younger sister Molly Lu. She is of Italian, Croatian, German, and Irish ancestry. She was baptized Catholic. Throughout her childhood, she was known by friends and family as a "nerdy", "awkward" kid, and she struggled with dyslexia and ADHD in school. She originally wanted to become an actress, and after attending West Seattle High School and Pacific Lutheran University, she moved to Los Angeles to pursue acting. Prior to her YouTube career, Pansino worked as a teacher in China and as a Methodist church secretary. Pansino's interest in cooking was inspired by her father and grandmother, and she stated in 2014 that "...baking has always been a hobby of mine. I have always loved being creative with my food and making themed sweets for my friends."
Sources: en.wikipedia.org
5 July King Charles III is presented with the Honours of Scotland during a ceremony held at Edinburgh's St Giles Cathedral. The Ministry of Defence confirms that UK Special Forces are at the centre of a war crimes investigation involving Afghanistan. David Black, the chief executive of Ofwat, suggests that water bills are likely to rise in 2025 as water companies seek to cover the cost of improving services. 6 July Two children die, while 15 other people are injured after a Land Rover crashes into a primary school in Wimbledon, south-west London. The crash is not treated as terror-related, but the driver is arrested on suspicion of causing death by dangerous driving. The Parliamentary Commissioner for Standards recommends that MP Chris Pincher be suspended for eight weeks, following an investigation into groping allegations. The government loses a High Court bid to prevent the COVID-19 Inquiry from seeing Boris Johnson's diaries and WhatsApp messages in full. Wallasey pub shooting: Connor Chapman is found guilty of shooting dead 26-year-old Elle Edwards and injuring four others with a submachine gun. Co-defendant Thomas Waring is also found guilty of possessing a prohibited firearm and assisting an offender. The following day, Chapman is sentenced to a minimum of 48 years in prison, and Waring is given a nine-year prison term. 7 July Consumer finance expert Martin Lewis speaks to BBC Radio 4 about the growing use of deepfake AI technology, warning that more regulation is needed to prevent online scams.
Treatments are patient-specific and depend on the symptoms that present with the disorder, as well as the progression of the condition. Improvements to the patient's life may be accomplished through the management of symptoms or slowing of the rate of demyelination. Treatment can include medication, lifestyle changes (i.e. smoking cessation, increased rest, and dietary changes), counselling, relaxation, physical exercise, patient education, and in some cases, deep brain thalamic stimulation (to ameliorate tremors).
But they were booked as one of the acts at the Altamont Music Festival. They played a short set, including "Bony Moronie" and "Six Days on the Road", which was included in the event's documentary Gimme Shelter. With mounting debt incurred, A&M hoped to recoup some of its losses by marketing the Burritos as a straight country group. Manager Jim Dickson instigated a session where the band recorded honky tonk staples and contemporary pop covers in a countrified vein, but this was scrapped in favor of a second album of originals on an extremely reduced budget. Faced with a dearth of new material, most of the album was hastily written in the studio by Leadon, Hillman, and Parsons, with two Gilded Palace of Sin outtakes thrown into the mix. The resulting album, Burrito Deluxe, was released in April 1970. Although it is considered less inspired than its predecessor, it is notable for the song "Older Guys" and for the band's take on "Wild Horses". Like its predecessor, Burrito Deluxe under-performed commercially but also failed to carry the critical cachet of the debut. Disenchanted, Parsons left the Burritos in mutual agreement with Hillman; under Hillman, the group recorded one more album before dissolving in 1971.
== Other poisonous plants == Many other plants not commonly used in food or drink are also poisonous, and care should be taken to avoid accidentally contacting or ingesting them. Some of these are popular ornamental plants or are cultivated for purposes other than consumption.
York Chow, the health secretary of Hong Kong, said he thought animal feeds might be the source of the contamination and announced that the Hong Kong Centre for Food Safety would henceforward be testing all mainland Chinese pork, farmed fish, animal feed, chicken meat, eggs, and offal products for melamine. As of July 2010, Chinese authorities were still reporting some seizures of melamine-contaminated dairy product in some provinces, though it was unclear whether these new contaminations constituted wholly new adulterations or were the result of illegal reuse of material from the 2008 adulterations. On characterization and treatment of urinary stones in affected infants, The New England Journal of Medicine printed an editorial in March 2009, along with reports on cases from Beijing, Hong Kong and Taipei. Urinary calculi specimens were collected from 15 cases treated in Beijing and were analyzed as unknown objects for their components at Beijing Institute of Microchemistry using infrared spectroscopy, nuclear magnetic resonance, and high performance liquid chromatography. The result of the analysis showed that the calculus was composed of melamine and uric acid, and the molecular ratio of uric acid to melamine was around 2:1.
Sources: en.wikipedia.org
Antiparasitics are a class of medications indicated for the treatment of infectious diseases such as leishmaniasis, malaria and Chagas disease, which are caused by parasites such as nematodes, cestodes, trematodes and infectious protozoa. Antiparasitic medications include metronidazole, iodoquinol and albendazole. Like all therapeutic antimicrobials, they must kill the infecting organism without serious damage to the host.
== Natural occurrences == Caffeic acid can be found in the bark of Eucalyptus globulus, the barley grain Hordeum vulgare, and the herb Dipsacus asperoides. It can also be found in the freshwater fern Salvinia molesta and in the mushroom Phellinus linteus.
=== Protein-based materials and sustainability === A major strand of Mezzenga's work concerns the development of protein-derived and food-based materials as sustainable platforms for advanced technologies. His group has pioneered the use of amyloid fibrils as building blocks for functional nanocomposites, including biodegradable materials with sensing and shape-memory properties. In 2016, Mezzenga and collaborators reported amyloid–carbon hybrid membranes for universal water purification. The technology exploits supramolecular metal–ligand interactions between heavy-metal ions and protein amyloid fibrils, allowing simultaneous removal of a wide range of contaminants with high binding affinities. The membranes exhibit unusually high permeability, enabling operation with minimal energy input. This research led to patented technologies and the creation of an ETH Zurich spin-off company, BluAct Technologies, which has tested and deployed the approach in multiple countries. Mezzenga has also contributed to the development of conceptual frameworks for evaluating the sustainability of water purification technologies at large, emphasizing energy efficiency and material performance.
Conventions, festivals and large events were permitted, and all businesses, schools, and places of recreation could be fully open. On July 15, 2020, Pritzker announced a new COVID-19 mitigation plan in the event of a resurgence of COVID-19. The metrics that would be used to determine whether COVID-19's spread in a region required additional mitigations were a sustained increase in 7-day rolling average (7 out of 10 days) in the positivity rate; and one of the following: a sustained 7-day increase in hospital admissions for a COVID-19 or the reduction in hospital capacity. Another metric was three consecutive days averaging greater than or equal to 8% positivity rate.
Sources: en.wikipedia.org
It is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, commonly referred to as hGH fragment 176-191. It has been investigated for effects on fat metabolism, but it is not an approved medication in most jurisdictions.
No. It is a shortened peptide fragment, not the full hormone. It does not contain the entire hGH sequence and is studied for different proposed effects.
Regulatory approvals for weight loss are not established in major jurisdictions. Some human trials reported modest changes, but the evidence is limited, and it remains a research compound.
No major medicines regulator appears to have approved AOD-9604 for human therapeutic use. It has been studied in clinical trials, but those programs did not result in a marketed drug.